While significantly elevated IL-6 levels were observed in T2D patients (median, 11.21 pg/mL; range, 3.09–47.24 pg/mL) as compared to CTLs (median, 7.53 pg/mL; range, 0.79–22.24 pg/mL; *P<0.05), we found no significant difference between MHO patients (median, 7.85 pg/mL; range, 3.16–40.12 pg/mL) and CTLs as well as T2D patients (P>0.05) (Fig. 3E). This evidence concerns the gene IL6 and type 2 diabetes mellitus.